S. Pepincovatta et al., IMMUNOREACTIVITY OF A NEW-GENERATION OF HORSE F(AB')(2) PREPARATIONS AGAINST EUROPEAN VIPER VENOMS AND THE TETANUS TOXIN, Toxicon, 35(3), 1997, pp. 411-422
The immunoreactivity of the current and the purified, pasteurized prep
arations of horse F(ab')(2) against the tetanus toxin and Vipera aspis
venom was investigated with a biosensor based on technology using the
optical phenomenon of surface plasmon resonance. Immunoreactivity dat
a were compared with seroneutralization titres. to investigate immunor
eactivity-immunoprotection efficacy relationships. To association-diss
ociation rate and affinity constants of the current and the new tetanu
s toxin-specific F(ab')(2) preparations were similar, at about 10(4) M
(-1) sec(-1), 10(-4) sec(-1) and 10(8) M(-1), respectively. Similar va
lues were found using a solid immunoradiometric assay. To assess the i
mmunoreactivity of V. aspis venom-specific horse F(ab')(2), the mol. w
t and percentage of the antigenic fractions of V. aspis venom were det
ermined. Western blotting of electrophoresis gels showed four antigeni
c fractions of V. aspis venom (mel, wts 17,500, 28,500, 32,000 and 60,
000), which represented 6, 3.4, 17.7 and 5% of total venom, respective
ly. Association and dissociation rate constants were in the same range
as those of the tetanus toxin-F(ab')(2) interactions for each of the
four antigenic fractions. Seroneutralization of both tetanus toxin and
V. aspis by the corresponding specific F(ab')(2) showed that the LD(5
0) mg(-1) protein was 1.76-fold and 1.51-fold higher with the new than
with the current preparations, respectively. These improvements in ef
ficacy were in close agreement with the higher immunoreactive fraction
ratios, which were 2-fold and 1.8-fold higher with the new preparatio
ns. These results demonstrate that the removal of non-IgG, immunoglobu
lins and the pasteurization treatment have no overall influence on F(a
b')(2) affinity but improve the specific activity of these new antitox
in horse F(ab')(2). (C) 1997 Elsevier Science Ltd.